Homepage
Author:
SOFIE BIOSCIENCES
Posted Date:
February 11, 2026
SOFIE Biosciences Announces First Patient Dosed in [18F]FAPI-74 Phase 3 Study for Pancreatic Cancer
SOFIE BIOSCIENCES
February 11, 2026
![SOFIE Biosciences Announces First Patient Dosed in [18F]FAPI-74 Phase 3 Study for Pancreatic Cancer](https://mma.prnewswire.com/media/562680/SOFIE_Logo.jpg){kind=logo}
